Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

BACKGROUND: To evaluate symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) as risk markers of cardiovascular disease, all-cause mortality and deterioration in renal function in a well characterised type 2 diabetic population with microalbuminuria and without symptoms of coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zobel, Emilie H., von Scholten, Bernt Johan, Reinhard, Henrik, Persson, Frederik, Teerlink, Tom, Hansen, Tine W., Parving, Hans-Henrik, Jacobsen, Peter K., Rossing, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505150/
https://www.ncbi.nlm.nih.gov/pubmed/28697799
http://dx.doi.org/10.1186/s12933-017-0569-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505150/
https://www.ncbi.nlm.nih.gov/pubmed/28697799
http://dx.doi.org/10.1186/s12933-017-0569-8

Ejemplares similares